Table 3 ESC Recommendations
From: How can developing countries harness biotechnology to improve health?
Africa | India | Eastern Mediterranean | Latin America and the Caribbean | Western Pacific/Southeast Asia |
|---|---|---|---|---|
N/A | - Engage the public and ensure broad-based input into policy setting - Ensure equitable access of poor to genomics products and services - Develop independent, accountable, transparent regulatory systems... based on ethics to ensure that ethical, legal and social issues are addressed | - The National Commission on Biotechnology should develop programs of public awareness and engagement. Important "publics" here include media and religious leaders as well as the public at large. The discussion should include ethical issues - The emphasis should be on accessibility and equity to improve the health of the poor | - The population of the countries in the region should be informed and educated about the developments in genomics and biotechnology, and in the impact of these disciplines in addressing local health needs | - Engage their publics in ways that inform, seek feedback and use the feedback to inform policy - Increase capacity for research and development on ethical, legal, environmental and social implications |